• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A low level of health literacy is a predictor of corticophobia in atopic dermatitis.健康素养水平低是特应性皮炎患者皮质恐惧症的预测指标。
An Bras Dermatol. 2022 Nov-Dec;97(6):704-709. doi: 10.1016/j.abd.2021.11.007. Epub 2022 Aug 31.
2
Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers.患有特应性皮炎幼儿的父母及其医疗服务提供者中的皮质类固醇恐惧症(皮质激素恐惧症)
Pediatr Dermatol. 2019 Jan;36(1):100-104. doi: 10.1111/pde.13698. Epub 2018 Oct 18.
3
Topical Corticosteroid Concerns Among Parents of Children with Psoriasis versus Atopic Dermatitis: A French Multicenter Cross-Sectional Study.儿童银屑病与特应性皮炎患儿家长的局部皮质类固醇担忧:法国多中心横断面研究。
Am J Clin Dermatol. 2018 Apr;19(2):261-265. doi: 10.1007/s40257-017-0318-5.
4
Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross-sectional study using TOPICOP in Japan.特应性皮炎患儿照料者的外用糖皮质激素恐惧症:一项在日本使用TOPICOP的横断面研究。
Pediatr Dermatol. 2019 May;36(3):311-316. doi: 10.1111/pde.13784. Epub 2019 Mar 18.
5
TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents.TOPICOP©:一种评估特应性皮炎门诊患者及其父母对外用皮质类固醇恐惧的新量表。
PLoS One. 2013 Oct 16;8(10):e76493. doi: 10.1371/journal.pone.0076493. eCollection 2013.
6
The Impact of Atopic Dermatitis and Corticophobia on the Quality of Family Life.特应性皮炎和皮质恐惧对家庭生活质量的影响。
Acta Dermatovenerol Croat. 2023 Aug;31(1):3-10.
7
Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores.特应性皮炎患儿家长的皮质恐惧:评估高TOPICOP评分的主要和次要风险因素
J Clin Med. 2023 Oct 27;12(21):6813. doi: 10.3390/jcm12216813.
8
Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey.特应性皮炎患儿家长对局部用皮质类固醇的恐惧:一项多中心调查
Ital J Pediatr. 2017 Feb 28;43(1):22. doi: 10.1186/s13052-017-0330-7.
9
Linguistic Validation and Reliability of the Croatian Version of the TOPICOP Questionnaire.《TOPICOP 问卷克罗地亚语版的语言验证和可靠性》。
Medicina (Kaunas). 2024 Jun 12;60(6):968. doi: 10.3390/medicina60060968.
10
Evaluation of corticophobia in patients with atopic dermatitis and psoriasis using the TOPICOP© score.采用 TOPICOP©评分评估特应性皮炎和银屑病患者的皮质恐惧症。
Acta Dermatovenerol Alp Pannonica Adriat. 2023 Dec;32(4):135-139.

引用本文的文献

1
Medication adherence in allergic diseases and asthma: a literature review.过敏性疾病和哮喘中的药物依从性:文献综述
Front Pharmacol. 2024 Dec 2;15:1488665. doi: 10.3389/fphar.2024.1488665. eCollection 2024.
2
Moving beyond biology: the critical role of social and structural determinants in atopic dermatitis.超越生物学范畴:社会和结构决定因素在特应性皮炎中的关键作用。
Int J Dermatol. 2025 Feb;64(2):272-281. doi: 10.1111/ijd.17491. Epub 2024 Sep 16.
3
Linguistic Validation and Reliability of the Croatian Version of the TOPICOP Questionnaire.《TOPICOP 问卷克罗地亚语版的语言验证和可靠性》。
Medicina (Kaunas). 2024 Jun 12;60(6):968. doi: 10.3390/medicina60060968.
4
Corticophobia and adherence to topical corticosteroids in atopic dermatitis treatment in southern Brazil.巴西南部特应性皮炎治疗中的皮质激素恐惧症与外用皮质类固醇激素的依从性
An Bras Dermatol. 2024 May-Jun;99(3):439-442. doi: 10.1016/j.abd.2023.04.008. Epub 2024 Feb 19.

本文引用的文献

1
Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis.减少药学工作人员和特应性皮炎患儿家长对皮质类固醇的恐惧。
Int J Clin Pharm. 2021 Oct;43(5):1237-1244. doi: 10.1007/s11096-021-01241-2. Epub 2021 Feb 13.
2
Atopic dermatitis.特应性皮炎。
Lancet. 2020 Aug 1;396(10247):345-360. doi: 10.1016/S0140-6736(20)31286-1.
3
Risk factors for corticophobia in atopic dermatitis.特应性皮炎中皮质恐惧的危险因素。
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e846-e849. doi: 10.1111/jdv.16739. Epub 2020 Jul 22.
4
Update on Atopic Dermatitis.特应性皮炎的最新进展
Acta Med Port. 2019 Sep 2;32(9):606-613. doi: 10.20344/amp.11963.
5
Does it work and is it safe? Parents' perspectives on adherence to medication for atopic dermatitis.它有效且安全吗?父母对特应性皮炎药物依从性的看法。
Pediatr Dermatol. 2020 Jan;37(1):58-61. doi: 10.1111/pde.13991. Epub 2019 Aug 28.
6
A systematic review of factors influencing treatment adherence in chronic inflammatory skin disease - strategies for optimizing treatment outcome.影响慢性炎症性皮肤病治疗依从性的因素的系统评价——优化治疗效果的策略。
J Eur Acad Dermatol Venereol. 2019 Dec;33(12):2253-2263. doi: 10.1111/jdv.15913. Epub 2019 Nov 14.
7
Topical Corticosteroid Phobia Among Healthcare Professionals Using the TOPICOP Score.医护人员使用 TOPICOP 评分对局部皮质类固醇恐惧症的评估。
Acta Derm Venereol. 2019 Oct 1;99(11):1004-1008. doi: 10.2340/00015555-3220.
8
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population.美国特应性皮炎研究:一项横断面研究,调查美国成年人群中特应性皮炎的患病率和疾病负担。
J Invest Dermatol. 2019 Mar;139(3):583-590. doi: 10.1016/j.jid.2018.08.028. Epub 2018 Oct 30.
9
Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers.患有特应性皮炎幼儿的父母及其医疗服务提供者中的皮质类固醇恐惧症(皮质激素恐惧症)
Pediatr Dermatol. 2019 Jan;36(1):100-104. doi: 10.1111/pde.13698. Epub 2018 Oct 18.
10
Epidemiology of adult atopic dermatitis.成人特应性皮炎的流行病学
Clin Dermatol. 2018 Sep-Oct;36(5):595-605. doi: 10.1016/j.clindermatol.2018.05.007. Epub 2018 May 31.

健康素养水平低是特应性皮炎患者皮质恐惧症的预测指标。

A low level of health literacy is a predictor of corticophobia in atopic dermatitis.

机构信息

Department of Dermatology, Centro Hospitalar de Leiria, Leiria, Portugal.

Department of Dermatology, Centro Hospitalar de Leiria, Leiria, Portugal.

出版信息

An Bras Dermatol. 2022 Nov-Dec;97(6):704-709. doi: 10.1016/j.abd.2021.11.007. Epub 2022 Aug 31.

DOI:10.1016/j.abd.2021.11.007
PMID:36057460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9582876/
Abstract

BACKGROUND

Topical corticosteroids (TCS) are the mainstay of treatment in atopic dermatitis (AD) flares. The fears and worries concerning TCS are known as corticophobia. Corticophobia is common in patients with AD and can lead to suboptimal TCS application and treatment failure. Health literacy (HL) may influence corticophobia. TOPICOP© and HLS-EU-PT questionnaires have been developed to evaluate corticophobia and HL, respectively.

OBJECTIVE

Evaluate the relationship between corticophobia and the degree of HL in patients with AD.

METHODS

Prospective cross-sectional study with AD patients followed at a Dermatology Department, between September 2019 and February 2020. Patients, or their parents (if patients had ≤ 15 years), were invited to answer TOPICOP© questionnaire, HLS-EU-PT questionnaire, and a disease characterization and demographic questionnaire.

RESULTS

We included 61 patients (57.4% females, mean age 20 ± 13.8 years, mean disease duration of 12.5 ± 11.4 years). TOPICOP© mean score was 44.8 ± 20.0 (8.3 to 88.9) and HLS-EU-PT mean score was 30.5 ± 8.5 (1.1 to 47.9). TOPICOP© score was negatively correlated with HLS-EU-PT score (p = 0.002, r = -0.382,  r = 0.146). There was no statistical difference between TOPICOP© score and disease characteristics (disease severity, family history of AD or personal history of other atopic diseases).

STUDY LIMITATIONS

Small and heterogenous cohort composed of patients and patients' parents.

CONCLUSION

The degree of corticophobia is similar to the values reported in other studies. HL had an inverse correlation with corticophobia. Lower HL was shown to be a predictor of higher corticophobia. The promotion of health literacy is essential for the correct use of TCS and good control of AD.

摘要

背景

在特应性皮炎(AD)发作时,局部皮质类固醇(TCS)是治疗的主要手段。人们对 TCS 的恐惧和担忧被称为皮质恐惧症。皮质恐惧症在 AD 患者中很常见,可能导致 TCS 应用不足和治疗失败。健康素养(HL)可能会影响皮质恐惧症。TOPICOP©和 HLS-EU-PT 问卷分别用于评估皮质恐惧症和 HL。

目的

评估 AD 患者的皮质恐惧症与 HL 程度之间的关系。

方法

这是一项前瞻性横断面研究,纳入了 2019 年 9 月至 2020 年 2 月在皮肤科就诊的 AD 患者。邀请患者或其父母(如果患者年龄≤15 岁)回答 TOPICOP©问卷、HLS-EU-PT 问卷和疾病特征及人口统计学问卷。

结果

共纳入 61 例患者(57.4%为女性,平均年龄 20±13.8 岁,平均疾病病程 12.5±11.4 年)。TOPICOP©平均得分为 44.8±20.0(8.3 至 88.9),HLS-EU-PT 平均得分为 30.5±8.5(1.1 至 47.9)。TOPICOP©评分与 HLS-EU-PT 评分呈负相关(p=0.002,r=-0.382,r=0.146)。TOPICOP©评分与疾病特征(疾病严重程度、AD 家族史或其他特应性疾病个人史)之间无统计学差异。

研究局限性

由患者及其父母组成的小且异质性队列。

结论

皮质恐惧症的程度与其他研究报告的数值相似。HL 与皮质恐惧症呈负相关。较低的 HL 被证明是皮质恐惧症升高的预测因素。促进健康素养对于 TCS 的正确使用和 AD 的良好控制至关重要。